Skip to Main Content
Forensic Genomics
investigator holding an evidence bag

Behind the Study: Investigate the MPS Feasibility and Guidance Report

Posted by Battelle Insider on Sep 18, 2017

After an exhaustive 19-month research project, massively parallel sequencing is proven to generate robust, reliable, reproducible results.

Toxicology
girl laying in hospital bed holding a teddy bear

3 Innovations Improving Safety Pharmacology Testing

Posted by Battelle Insider on Sep 11, 2017

Toxicology safety testing teams are under more pressure than ever. Here are three significant innovations helping tox teams achieve more success.

CBRNE Defense
researcher working in a lab

Bringing Down Barriers to Medical Countermeasure Development

Posted by Russell Coleman on Aug 29, 2017

To meet the need for new vaccines for chemical & biological weapons, federal agencies & private companies must work together to overcome barriers.

Forensic Genomics
researcher working in an MPS lab

What the MPS Feasibility Report Means for Forensic Science Today

Posted by Battelle Insider on Aug 17, 2017

Massively Parallel Sequencing has been the talk of DNA scientists, but now it’s closer than ever to becoming a valid asset for law enforcement.

Cybersecurity
Chris Domas on stage presenting during an event

Sandsifter to Make Debut at Black Hat 2017

Posted by Battelle Insider on Jul 25, 2017

Cyber Scientist Chris Domas heads to Black Hat to share his findings from a deep dive into x86 processors using a new tool called Sandsifter.

CBRNE Defense
people in chem-bio suits carrying an injured person

Understanding the Barriers to Medical Countermeasure Development

Posted by Russell Coleman on Jul 20, 2017

There is an urgent need for new medical countermeasures for CBRN threats. Why isn’t the industry providing them?

Cyber
circuit board

Addressing Hardware Cybersecurity

Posted by Battelle Insider on Jul 13, 2017

A vulnerability in software is a problem. A vulnerability in hardware is a disaster. They’re nearly impossible to fix and incredibly costly.

Search